Assessing the Impact of Probiotic Supplementation and Caloric Periodization on Ultra-endurance Performance and Gastrointestinal Symptoms by Roberts, Justin D. et al.
Assessing the Impact of Probiotic Supplementation and Caloric Periodization on 
Ultra-endurance Performance and Gastrointestinal Symptoms. 
  
Justin D. Roberts1, Craig A. Suckling1, Georgia Y. Peedle1, Dan A. Gordon1, Hannah 
Marshall2, Lee Taylor3 and Michael G. Roberts4. Anglia Ruskin University, United 
Kingdom1; University of Bedfordshire, United Kingdom2; ASPETAR, Qatar 
Orthopaedic and Sports Medicine Hospital, Qatar; University of Hertfordshire, United 
Kingdom4. 
 
Beneficial use of probiotic (PRO) interventions on gastrointestinal endotoxemia (GE) 
prior to an ultra-endurance triathlon has been previously demonstrated. The 
prevalence of GE (and whether PRO strategies minimise gastrointestinal (GI) 
symptoms) relating to multi-day ultra-events is less known. Understanding if nutritional 
periodization strategies confer similar GI benefits also warrants investigation.  
 
PURPOSE: To assess the impact of probiotic supplementation and caloric 
periodization prior to an extreme ultra-marathon on GI symptoms and race 
performance.  
 
METHODS: Thirty-eight healthy participants were recruited from entrants of the 2015 
Marathon Des Sables (age: 42±9yrs; weight: 77.71±10.31kg; VO2max: 52.58±8.66 
mL·kg·min-1), and randomly assigned to either: PRO (100mg.d-1 capsulated 
Lactobacillus acidophilus); CP (caloric periodization of 500kcal above habitual intake 
on alternate days) or control (CON) for 12 weeks pre-race. Plasma lipopolysaccharides 
(LPS) via Limulus Amebocyte Lysate chromogenic endotoxin quantification were 
determined at baseline, pre and post-race. Participants graded duration and severity 
of GI symptoms through daily questionnaires. Performance times were obtained from 
accumulated race tracking. Data presented as mean ±SE.  
 
RESULTS: Race times (hrs:mins) were  41:28±2:31, 45:12±2:05 and 50:43 ±4:38 for 
PRO, CP and CON respectively (p>0.05). Overall LPS significantly increased from 
baseline (10.08±0.53pg.ml-1) to pre-race (13.12±0.74pg.ml-1; p=0.001). Delta LPS pre-
race was not different between groups (PRO: 2.94±1.11pg.ml-1; CP: 3.71±1.28pg.ml-
1; CON: 2.32±1.26pg.ml-1; p>0.05). Similarly, delta LPS post-race was not different, 
despite greater reductions in both intervention groups (PRO: -4.57±1.93pg.ml-1; CP: -
6.95±1.84pg.ml-1; CON: -2.16±2.21pg.ml-1; p>0.05). GI symptom count favoured PRO 
(21.8%) compared with CP (41.6%) and CON (36.6%) respectively (p=0.001), 
although no differences for GI symptom index were reported between groups (p>0.05).  
 
CONCLUSIONS: Moderate GE was evident in a UK cohort undertaking a multi-day 
ultra-marathon. PRO use did not significantly impact on GE prevalence, despite 
evidence of reduced GI symptoms. Caloric periodization appeared to favour GE 
recovery post-race, but was not deemed significant.  
 
 
 
